SHANGHAI JUNSHI BIO YC1 Working Capital to Net Assets Ratio
SHANGHAI JUNSHI BIO YC1 working capital to net assets ratio. SHANGHAI JUNSHI BIO YC1 (8SJ) has a Working Capital to Net Assets ratio of 27.1% as of December 2025. Working capital of €1.65 Billion (current assets of €4.46 Billion minus current liabilities of €2.81 Billion) is measured against net assets of €6.07 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 8SJ goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SHANGHAI JUNSHI BIO YC1 (2021–2025)
Working capital to net assets ratio of SHANGHAI JUNSHI BIO YC1 from 2021 to 2025. This chart shows how SHANGHAI JUNSHI BIO YC1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 27.1%, reflecting working capital of €1.65 Billion against net assets of €6.07 Billion EUR. See 8SJ days of operational coverage to measure how many days the company can operate on defensive assets alone.
SHANGHAI JUNSHI BIO YC1 Working Capital to Net Assets Ratio by Year (2021–2025)
SHANGHAI JUNSHI BIO YC1 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SHANGHAI JUNSHI BIO YC1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 8SJ total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.1% | €1.65 Billion | €6.07 Billion | €4.46 Billion | €2.81 Billion | ▼ -2.3 pp |
| 2024 | 29.4% | €1.75 Billion | €5.95 Billion | €4.28 Billion | €2.53 Billion | ▼ -12.5 pp |
| 2023 | 41.9% | €3.07 Billion | €7.34 Billion | €5.55 Billion | €2.48 Billion | ▼ -13.6 pp |
| 2022 | 55.4% | €5.43 Billion | €9.79 Billion | €7.20 Billion | €1.77 Billion | ▲ +9.7 pp |
| 2021 | 45.8% | €3.82 Billion | €8.33 Billion | €5.83 Billion | €2.02 Billion | — |